Contact this trialFirst, we need to learn more about you.
Anti-inflammatory
Xiflam for Post-COVID Syndrome
Recruiting0 awardsPhase 2
Waltham, Massachusetts
This trial aims to test if Xiflam is safe and effective compared to a placebo for patients with Long COVID. Xiflam or placebo will be given orally once a day for 12 weeks to
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service